1249609

Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. — FEI 1000208638

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bristol, TN (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
180921 CFR 211.160(a)Following/documenting laboratory controls
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
356521 CFR 211.58Buildings not maintained in good state of repair
430321 CFR 211.67(b)Written procedures fail to include